Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified July 2012 by Ziopharm.
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborator:
Memorial Sloan Kettering Cancer Center
Information provided by (Responsible Party):
Ziopharm
ClinicalTrials.gov Identifier:
NCT01113970
First received: April 8, 2010
Last updated: January 29, 2013
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2013
  Estimated Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)